http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6718204-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3688
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-39622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3956
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3622
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-365
filingDate 2001-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce74bc92332777355df1a21cd7c5ae5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6c2c96267be554553f7bad322b666f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_386ec844c12f12f34844bcd940ef24e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d61eb42597ddae747e188410f41c19c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99ce186f497ac93726117a23d83c11e7
publicationDate 2004-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6718204-B2
titleOfInvention Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device
abstract A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8639323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144028-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9610025-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007270911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197630-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143851-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009099611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9636504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006023517-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1857140-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2859914-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10065045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2674194-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10220213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9795312-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007156189-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10244957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11751793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9526908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534617-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004181259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7151962-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10252067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10278601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8170663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245980-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7280869-B2
priorityDate 2001-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5318591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4407288-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5713924-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5251624-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4821723-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4865036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5193535-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4830006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4407288-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23565373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423143485

Total number of triples: 77.